TransMedics Group, Inc. (TMDX) Social Stream

Featured Post From StockTwits About TMDX

$TMDX "Second, the OCS Liver PMA. In July, we secured a nearly unanimous positive panel vote supporting the approval of the OCS Liver for both DBD and DCD indications. We're now actively engaged with FDA review team to finalize the labeling and post-approval program. We are confident that we are proceeding towards approval of the OCS Liver indications before year-end."~ W. Hassanein